A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the ...
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.